GI Innovation Inc. Logo

GI Innovation Inc.

Researches and develops protein-based drugs for immuno-oncology and immunology.

358570 | KO

Overview

Corporate Details

ISIN(s):
KR7358570000
LEI:
Country:
South Korea
Address:
서울특별시 송파구 송파대로 167, 서울특별시

Description

GI Innovation Inc. is a bio-venture company that researches and develops innovative protein-based drugs. The company utilizes its proprietary GI-SMART™ platform to create novel biologics, focusing on immuno-oncology and immunology-related diseases. Its development pipeline includes key candidates such as GI-101, an immuno-oncology treatment, and GI-301 for IgE-mediated allergic diseases. The company's approach is guided by its 'Science, Strategy, Speed' (3S) strategy, which integrates basic science with translational research to accelerate drug development.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2026-01-08 00:00
전환사채(해외전환사채포함)발행후만기전사채취득 (제1회차)
Korean HTML 9.2 KB
2026-01-07 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.6 KB
2026-01-07 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.6 KB
2026-01-07 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.6 KB
2025-12-23 00:00
주요사항보고서(제3자의전환사채매수선택권행사)
Korean HTML 35.0 KB
2025-09-12 00:00
투자판단관련주요경영사항(임상시험계획승인신청) (건강한 성인 및 암 생존자를 대상으로 한 GI102 요법의 노화 관련 생…
Korean HTML 8.2 KB
2025-09-05 00:00
투자판단관련주요경영사항(임상시험계획변경승인신청) (GI101 단일 요법 또는 펨브롤리주맙 또는 렌바티닙 병용 요법의 안…
Korean HTML 13.0 KB
2025-09-04 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.3 KB
2025-09-04 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 25.2 KB
2025-09-04 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.5 KB
2025-09-04 00:00
주식등의대량보유상황보고서(일반)
Korean HTML 957.2 KB
2025-08-29 00:00
전환주식의전환청구권행사 (전환우선주)
Korean HTML 15.3 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean HTML 1.2 MB
2025-08-05 00:00
주요사항보고서(전환사채매수선택권행사자지정)
Korean HTML 23.8 KB
2025-07-10 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.3 KB

Automate Your Workflow. Get a real-time feed of all GI Innovation Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GI Innovation Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GI Innovation Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alpha Tau Medical Ltd. Logo
Clinical-stage oncology firm developing alpha radiation therapy for solid tumors.
United States of America
DRTS
Alteogen Inc. Logo
Biopharmaceutical firm developing biologics with proprietary drug delivery technologies.
South Korea
196170
AlzeCure Pharma Logo
Develops therapies for severe diseases, focusing on Alzheimer's and pain.
Sweden
ALZCUR
ANAPTYSBIO, INC Logo
Clinical-stage biotech developing immunology therapeutics for inflammatory diseases.
United States of America
ANAB
AngioLab, Inc. Logo
Develops angiogenesis inhibitors for pharmaceuticals and health functional foods.
South Korea
251280
Anixa Biosciences Inc Logo
A clinical-stage biotech developing therapies and vaccines to treat and prevent cancer.
United States of America
ANIX
Annovis Bio, Inc. Logo
A clinical-stage drug platform company developing therapies for neurodegenerative diseases.
United States of America
ANVS
Develops and manufactures DNA-based technologies for genetic medicine and diagnostics.
United States of America
APDN
Aprea Therapeutics, Inc. Logo
Clinical-stage biopharma developing cancer therapeutics via synthetic lethality.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases, oncology, and rare diseases.
South Korea
397030

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.